Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:49 UTC |
---|
Update Date | 2022-03-07 02:51:39 UTC |
---|
HMDB ID | HMDB0014511 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Levonorgestrel |
---|
Description | Levonorgestrel, also known as microlut or norplant, belongs to the class of organic compounds known as estrogens and derivatives. These are steroids with a structure containing a 3-hydroxylated estrane. Thus, levonorgestrel is considered to be a steroid lipid molecule. Levonorgestrel is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. Levonorgestrel is a potentially toxic compound. |
---|
Structure | [H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H] InChI=1S/C21H28O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,13,16-19,23H,3,5-12H2,1H3/t16-,17+,18+,19-,20-,21-/m0/s1 |
---|
Synonyms | Value | Source |
---|
(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one | ChEBI | 13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one | ChEBI | 13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one | ChEBI | 13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one | ChEBI | 17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one | ChEBI | 17-alpha-Ethynyl-13-ethyl-19-nortestosterone | ChEBI | 17-Ethynyl-18-methyl-19-nortestosterone | ChEBI | 17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol | ChEBI | 17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one | ChEBI | 17alpha-Ethynyl-18-homo-19-nortestosterone | ChEBI | 18-Methyl-17-alpha-ethynyl-19-nortestosterone | ChEBI | 18-Methylnorethisterone | ChEBI | D(-)-Norgestrel | ChEBI | Jadelle | ChEBI | Levonelle | ChEBI | Levonorgestrelum | ChEBI | Levonova | ChEBI | Microlut | ChEBI | Microluton | ChEBI | Microval | ChEBI | Mirena | ChEBI | NorLevo | ChEBI | Plan b | ChEBI | Postinor | ChEBI | (+-)-Norgestrel | Kegg | Ovrette | Kegg | (-)-13-Ethyl-17-hydroxy-18,19-dinor-17a-pregn-4-en-20-yn-3-one | Generator | (-)-13-Ethyl-17-hydroxy-18,19-dinor-17α-pregn-4-en-20-yn-3-one | Generator | 13-b-Ethyl-17a-ethynyl-17b-hydroxygon-4-en-3-one | Generator | 13-Β-ethyl-17α-ethynyl-17β-hydroxygon-4-en-3-one | Generator | 13-Ethyl-17-a-ethynyl-17-b-hydroxy-4-gonen-3-one | Generator | 13-Ethyl-17-α-ethynyl-17-β-hydroxy-4-gonen-3-one | Generator | 13-Ethyl-17-a-ethynylgon-4-en-17-b-ol-3-one | Generator | 13-Ethyl-17-α-ethynylgon-4-en-17-β-ol-3-one | Generator | 17-a-Ethinyl-13-b-ethyl-17-b-hydroxy-4-estren-3-one | Generator | 17-Α-ethinyl-13-β-ethyl-17-β-hydroxy-4-estren-3-one | Generator | 17-a-Ethynyl-13-ethyl-19-nortestosterone | Generator | 17-Α-ethynyl-13-ethyl-19-nortestosterone | Generator | 17a-Ethynyl-13b-ethyl-3-oxo-4-estren-17b-ol | Generator | 17Α-ethynyl-13β-ethyl-3-oxo-4-estren-17β-ol | Generator | 17a-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one | Generator | 17Α-ethynyl-17-hydroxy-18-methylestr-4-en-3-one | Generator | 17a-Ethynyl-18-homo-19-nortestosterone | Generator | 17Α-ethynyl-18-homo-19-nortestosterone | Generator | 18-Methyl-17-a-ethynyl-19-nortestosterone | Generator | 18-Methyl-17-α-ethynyl-19-nortestosterone | Generator | Levonorgestrel alcala brand | HMDB | Levonorgestrel hexal brand | HMDB | Norplant | HMDB | Paladin brand OF levonorgestrel | HMDB | Vikela | HMDB | Wyeth brand OF levonorgestrel | HMDB | Duofem | HMDB | L-Norgestrel | HMDB | Aventis pharma brand OF levonorgestrel | HMDB | Berlex brand OF levonorgestrel | HMDB | HRA brand 1 OF levonorgestrel | HMDB | Hexal brand OF levonorgestrel | HMDB | Levonorgestrel paladin brand | HMDB | Levonorgestrel wyeth brand | HMDB | Norplant 2 | HMDB | Alcala brand OF levonorgestrel | HMDB | Capronor | HMDB | Cerazet | HMDB | D-Norgestrel | HMDB | HRA brand 2 OF levonorgestrel | HMDB | Norplant-2 | HMDB | Schering brand 3 OF levonorgestrel | HMDB | L Norgestrel | HMDB | D Norgestrel | HMDB | Levonorgestrel berlex brand | HMDB | Norgeston | HMDB | Norplant2 | HMDB | Schering brand 1 OF levonorgestrel | HMDB | Schering brand 2 OF levonorgestrel | HMDB | Women's capital brand OF levonorgestrel | HMDB | Levonorgestrel | MeSH |
|
---|
Chemical Formula | C21H28O2 |
---|
Average Molecular Weight | 312.4458 |
---|
Monoisotopic Molecular Weight | 312.20893014 |
---|
IUPAC Name | (1S,2R,10R,11S,14R,15S)-15-ethyl-14-ethynyl-14-hydroxytetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one |
---|
Traditional Name | (1S,2R,10R,11S,14R,15S)-15-ethyl-14-ethynyl-14-hydroxytetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one |
---|
CAS Registry Number | 797-63-7 |
---|
SMILES | [H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H] |
---|
InChI Identifier | InChI=1S/C21H28O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,13,16-19,23H,3,5-12H2,1H3/t16-,17+,18+,19-,20-,21-/m0/s1 |
---|
InChI Key | WWYNJERNGUHSAO-XUDSTZEESA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as estrogens and derivatives. These are steroids with a structure containing a 3-hydroxylated estrane. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Estrane steroids |
---|
Direct Parent | Estrogens and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Estrogen-skeleton
- 3-oxo-delta-4-steroid
- 3-oxosteroid
- 17-hydroxysteroid
- Oxosteroid
- Hydroxysteroid
- Delta-4-steroid
- Cyclohexenone
- Ynone
- Cyclic alcohol
- Tertiary alcohol
- Cyclic ketone
- Ketone
- Acetylide
- Organic oxygen compound
- Hydrocarbon derivative
- Organic oxide
- Carbonyl group
- Alcohol
- Organooxygen compound
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | - terminal acetylenic compound (CHEBI:6443 )
- 3-oxo Delta(4)-steroid (CHEBI:6443 )
- 17beta-hydroxy steroid (CHEBI:6443 )
- Pregnane and derivatives [Fig] (C08153 )
- C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives (C08153 )
- C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives (LMST02030119 )
|
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 240 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.0058 g/L | Not Available | LogP | 3.8 | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times UnderivatizedChromatographic Method | Retention Time | Reference |
---|
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 7.6 minutes | 32390414 | Predicted by Siyang on May 30, 2022 | 16.7629 minutes | 33406817 | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.18 minutes | 32390414 | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2577.7 seconds | 40023050 | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 423.5 seconds | 40023050 | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 210.9 seconds | 40023050 | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 198.9 seconds | 40023050 | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 469.4 seconds | 40023050 | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 804.1 seconds | 40023050 | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 751.1 seconds | 40023050 | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 92.3 seconds | 40023050 | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1460.4 seconds | 40023050 | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 473.2 seconds | 40023050 | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1485.0 seconds | 40023050 | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 477.4 seconds | 40023050 | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 435.4 seconds | 40023050 | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 291.8 seconds | 40023050 | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 497.3 seconds | 40023050 | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 15.6 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Levonorgestrel,1TMS,isomer #1 | C#C[C@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC | 2867.1 | Semi standard non polar | 33892256 | Levonorgestrel,1TMS,isomer #2 | C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@@H]4[C@H]3CC[C@@]21CC | 2760.1 | Semi standard non polar | 33892256 | Levonorgestrel,2TMS,isomer #1 | C#C[C@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@@H]4[C@H]3CC[C@@]21CC | 2837.5 | Semi standard non polar | 33892256 | Levonorgestrel,2TMS,isomer #1 | C#C[C@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@@H]4[C@H]3CC[C@@]21CC | 2914.3 | Standard non polar | 33892256 | Levonorgestrel,2TMS,isomer #1 | C#C[C@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@@H]4[C@H]3CC[C@@]21CC | 3258.3 | Standard polar | 33892256 | Levonorgestrel,1TBDMS,isomer #1 | C#C[C@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC | 3128.6 | Semi standard non polar | 33892256 | Levonorgestrel,1TBDMS,isomer #2 | C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@@H]4[C@H]3CC[C@@]21CC | 3025.5 | Semi standard non polar | 33892256 | Levonorgestrel,2TBDMS,isomer #1 | C#C[C@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@@H]4[C@H]3CC[C@@]21CC | 3345.5 | Semi standard non polar | 33892256 | Levonorgestrel,2TBDMS,isomer #1 | C#C[C@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@@H]4[C@H]3CC[C@@]21CC | 3383.2 | Standard non polar | 33892256 | Levonorgestrel,2TBDMS,isomer #1 | C#C[C@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@@H]4[C@H]3CC[C@@]21CC | 3436.9 | Standard polar | 33892256 |
|
---|